![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/337 | |
A61K 31/416 | |||
A61K 31/513 | |||
A61K 31/517 | |||
A61K 31/5355 | |||
A61K 31/555 | |||
A61K 39/395 | |||
A61K 45/06 | |||
A61P 35/00 | |||
G01N 33/574 | |||
A61K 47/48 | |||
A61K 31/5377 |
(11) | Patento numeris | 2254571 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 09721522.2 |
Europos patento paraiškos padavimo data | 2009-03-10 | |
(97) | Europos patento paraiškos paskelbimo data | 2010-12-01 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-01 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2009/036608 |
Data | 2009-03-10 |
(87) | Numeris | WO 2009/117277 |
Data | 2009-09-24 |
(30) | Numeris | Data | Šalis |
37410 P | 2008-03-18 | US |
(72) |
BERRY, Leanne, US
PHILLIPS, Gail, Lewis, US
SLIWKOWSKI, Mark, X., US
|
(73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
(54) | COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE |
COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE |